Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus
Top Cited Papers
- 1 December 2013
- journal article
- Published by Elsevier in Journal of Infection
- Vol. 67 (6) , 606-616
- https://doi.org/10.1016/j.jinf.2013.09.029
Abstract
No abstract availableKeywords
Funding Information
- Consultancy Service for Enhancing Laboratory Surveillance of Emerging Infectious Disease of the Department of Health
- National Science and Technology Major Project of China (2012ZX10004-213-002)
This publication has 74 references indexed in Scilit:
- MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatmentJournal of General Virology, 2013
- Suppression of Coronavirus Replication by Cyclophilin InhibitorsViruses, 2013
- Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirinScientific Reports, 2013
- Human Betacoronavirus 2c EMC/2012–related Viruses in Bats, Ghana and EuropeEmerging Infectious Diseases, 2013
- Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell LinesmBio, 2012
- Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in HumansmBio, 2012
- Severe Acute Respiratory Syndrome Coronavirus Replication Inhibitor That Interferes with the Nucleic Acid Unwinding of the Viral HelicaseAntimicrobial Agents and Chemotherapy, 2012
- Two Years after Pandemic Influenza A/2009/H1N1: What Have We Learned?Clinical Microbiology Reviews, 2012
- Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virusProceedings of the National Academy of Sciences, 2008
- Severe Acute Respiratory Syndrome Coronavirus as an Agent of Emerging and Reemerging InfectionClinical Microbiology Reviews, 2007